International Journal of Stroke, Ahead of Print. Background:Utilization of oral anticoagulants for acute ischemic stroke (AIS) prevention in patients with atrial fibrillation (AF) increased in the United States over the last decade. Whether this increa…
International Journal of Stroke, Ahead of Print. Background:Disparities in the availability of reperfusion services for acute ischemic stroke are considerable globally and require urgent attention. Contemporary data on the availability of reperfusion s…
International Journal of Stroke, Volume 19, Issue 1, Page 4-6, January 2024.
International Journal of Stroke, Ahead of Print. Background:Post-stroke fatigue (PSF) affects 50% of stroke survivors. Current guidance on management of this condition is limited.Aims:This systematic review and meta-analysis aimed to identify and analy…
International Journal of Stroke, Ahead of Print. Background:Post-stroke fatigue (PSF) affects 50% of stroke survivors. Current guidance on management of this condition is limited.Aims:This systematic review and meta-analysis aimed to identify and analy…
International Journal of Stroke, Ahead of Print. Background:Endovascular thrombectomy (EVT) and intravenous thrombolysis (IVT) have an unclear benefit in those with pre-stroke dementia or cognitive impairment, as these patients were often excluded from…
International Journal of Stroke, Ahead of Print. Background:Recent years have seen a change in the use of anticoagulants in the general population due to the availability of direct oral anticoagulants (DOACs) as an alternative to vitamin K antagonists …
International Journal of Stroke, Ahead of Print. Background:Recent years have seen a change in the use of anticoagulants in the general population due to the availability of direct oral anticoagulants (DOACs) as an alternative to vitamin K antagonists …
International Journal of Stroke, Ahead of Print. Background:CD34 is a transmembrane phosphoglycoprotein and a marker of hematopoietic and nonhematopoietic stem/progenitor cells. In experimental studies, CD34+ cells are rich sources of endothelial proge…
International Journal of Stroke, Ahead of Print. Background:CD34 is a transmembrane phosphoglycoprotein and a marker of hematopoietic and nonhematopoietic stem/progenitor cells. In experimental studies, CD34+ cells are rich sources of endothelial proge…